Avanza Fonder Ab Mirum Pharmaceuticals, Inc. Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 2,878 shares of MIRM stock, worth $125,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,878
Previous 4,564
36.94%
Holding current value
$125,049
Previous $189 Million
31.37%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
217Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$285 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$199 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$141 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$122 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$113 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.6B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...